California Code of Regulations › Title 17 - Public Health › Division 4 - California Institute for Regenerative Medicine › Chapter 6 - Intellectual Property and Revenue Sharing Requirements for Non-Profit and for-Profit Grantees › Section 100603 - Publication Requirements

Current through Register 2024 Notice Reg. No. 28, July 12, 2024
(a)
				A Grantee must provide for public access to any publication of a CIRM-Funded
				Invention or CIRM-Funded Technology, as provided in this section.
(b) For any manuscript that is peer-reviewed
				and accepted for publication in a scientific journal, the Grantee must ensure
				that an electronic version of the final peer-reviewed manuscript is submitted
				to PubMed Central or to CIRM to be made publicly available no later than 12
				months after the official date of publication. The Grantee shall make
				reasonable efforts to comply with this requirement through submission to PubMed
				Central, including notifying CIRM of the PubMed Central identification number.
				If the Grantee is unable to submit the manuscript to PubMed Central, the
				Grantee may comply by providing the manuscript to CIRM, no later than 12 months
				after the official date of publication. In lieu of the final peer-reviewed
				manuscript, the Grantee may submit the final published article.
(c) For publications other than those
				described in subsection (b), including meeting abstracts, the Grantee must
				comply by providing the manuscript to CIRM no later than 12 months after the
				official date of publication.
(d)
				Grantees are responsible for ensuring that any publishing or copyright
				agreements concerning submitted articles fully comply with this
				Regulation.
(e) Within 60 calendar
				days of the publication, Grantees shall notify CIRM of the Grant Number,
				Grantee Institution, Principal Investigator and the PubMed Central
				identification number for the manuscript. In addition, Grantees shall provide
				CIRM with a short paragraph, written for the general public, describing both
				the importance of the discovery that is the subject of the publication and the
				approach or methodology employed. Neither the publication abstract nor the
				statement of public benefit submitted as part of the application satisfy this
				requirement.
(f) A Grantee must
				ensure that the final abstract or manuscript includes the URL of a website
				where a Materials Transfer Agreement (or similar document) can be accessed to
				facilitate requests for Publication-related Biomedical Materials.
(g) Any written or oral publication reporting
				a CIRM-Funded Invention or CIRM-Funded Technology must acknowledge CIRM
				funding. An example of an acknowledgement is:
"This research was made possible by a grant from the
				  California Institute for Regenerative Medicine (Grant Number __________). The
				  contents of this publication are solely the responsibility of the authors and
				  do not necessarily represent the official views of CIRM or any other agency of
				  the State of California."
1. New section
				  filed 12-17-2009; operative 12-17-2009 pursuant to Government Code section
				  11343.4
				  (Register 2009, No. 51). For prior history, see Register 2007, No.
				  26.
2. Repealer and new subsections (a) and (b), new subsections
				  (c)-(e) and subsection relettering filed 3-21-2013; operative 7-1-2013
				  (Register 2013, No. 12).
Note: Authority cited: Article XXXV, California
					 Constitution; and Section
					 125290.40(j),
					 Health and Safety Code. Reference: Section
					 125290.30,
					 Health and Safety Code.